Variation in hospital risk-adjusted mortality rates following transcatheter aortic valve replacement in the United States

Sean M. O'Brien, David J. Cohen, John S. Rumsfeld, J. Matthew Brennan, David M. Shahian, David Dai, David Holmes, Rosemarie B. Hakim, Vinod H. Thourani, Eric D. Peterson, Fred H. Edwards

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background - The use of transcatheter aortic valve replacement (TAVR) to treat aortic stenosis in the United States is growing, yet little is known about the variation in procedural outcomes in community practice. We developed a TAVR in-hospital mortality risk model and used it to quantify variation in mortality rates across United States (US) TAVR centers. Methods and Results - We analyzed data from 22 248 TAVR procedures performed at 318 sites participating in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (November 2011 to October 2014). A Bayesian hierarchical model was developed to estimate hospital-specific risk-adjusted mortality rates adjusting for 40 patient baseline factors. A total of 1130 in-hospital deaths (5.1%) were observed. Reliability-adjusted risk-adjusted mortality rate estimates ranged from 3.4% to 7.7% with an interquartile range of 4.8% to 5.4%. A patient's predicted odds of dying was 80% higher if treated by a hospital 1 standard deviation above the mean compared with a hospital 1 standard deviation below the mean (odds ratio =1.8; 95% credible interval, 1.4%-2.2%). Conclusions - Risk modeling of TAVR in-hospital mortality revealed variation in risk-adjusted mortality rates during the US early commercial experience. Transcatheter Valve Therapy Registry analyses using this model will support research, feedback reporting, and the identification of factors associated with quality.

Original languageEnglish (US)
Pages (from-to)560-565
Number of pages6
JournalCirculation: Cardiovascular Quality and Outcomes
Volume9
Issue number5
DOIs
StatePublished - Sep 1 2016

Fingerprint

Mortality
Hospital Mortality
Registries
Aortic Valve Stenosis
Odds Ratio
Transcatheter Aortic Valve Replacement
Therapeutics
Research

Keywords

  • aortic stenosis
  • case-mix adjustment
  • outcomes analysis
  • outcomes research
  • transcatheter aortic valve replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Variation in hospital risk-adjusted mortality rates following transcatheter aortic valve replacement in the United States. / O'Brien, Sean M.; Cohen, David J.; Rumsfeld, John S.; Brennan, J. Matthew; Shahian, David M.; Dai, David; Holmes, David; Hakim, Rosemarie B.; Thourani, Vinod H.; Peterson, Eric D.; Edwards, Fred H.

In: Circulation: Cardiovascular Quality and Outcomes, Vol. 9, No. 5, 01.09.2016, p. 560-565.

Research output: Contribution to journalArticle

O'Brien, SM, Cohen, DJ, Rumsfeld, JS, Brennan, JM, Shahian, DM, Dai, D, Holmes, D, Hakim, RB, Thourani, VH, Peterson, ED & Edwards, FH 2016, 'Variation in hospital risk-adjusted mortality rates following transcatheter aortic valve replacement in the United States', Circulation: Cardiovascular Quality and Outcomes, vol. 9, no. 5, pp. 560-565. https://doi.org/10.1161/CIRCOUTCOMES.116.002756
O'Brien, Sean M. ; Cohen, David J. ; Rumsfeld, John S. ; Brennan, J. Matthew ; Shahian, David M. ; Dai, David ; Holmes, David ; Hakim, Rosemarie B. ; Thourani, Vinod H. ; Peterson, Eric D. ; Edwards, Fred H. / Variation in hospital risk-adjusted mortality rates following transcatheter aortic valve replacement in the United States. In: Circulation: Cardiovascular Quality and Outcomes. 2016 ; Vol. 9, No. 5. pp. 560-565.
@article{d72d2597cb0042559bd5367047d6756a,
title = "Variation in hospital risk-adjusted mortality rates following transcatheter aortic valve replacement in the United States",
abstract = "Background - The use of transcatheter aortic valve replacement (TAVR) to treat aortic stenosis in the United States is growing, yet little is known about the variation in procedural outcomes in community practice. We developed a TAVR in-hospital mortality risk model and used it to quantify variation in mortality rates across United States (US) TAVR centers. Methods and Results - We analyzed data from 22 248 TAVR procedures performed at 318 sites participating in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (November 2011 to October 2014). A Bayesian hierarchical model was developed to estimate hospital-specific risk-adjusted mortality rates adjusting for 40 patient baseline factors. A total of 1130 in-hospital deaths (5.1{\%}) were observed. Reliability-adjusted risk-adjusted mortality rate estimates ranged from 3.4{\%} to 7.7{\%} with an interquartile range of 4.8{\%} to 5.4{\%}. A patient's predicted odds of dying was 80{\%} higher if treated by a hospital 1 standard deviation above the mean compared with a hospital 1 standard deviation below the mean (odds ratio =1.8; 95{\%} credible interval, 1.4{\%}-2.2{\%}). Conclusions - Risk modeling of TAVR in-hospital mortality revealed variation in risk-adjusted mortality rates during the US early commercial experience. Transcatheter Valve Therapy Registry analyses using this model will support research, feedback reporting, and the identification of factors associated with quality.",
keywords = "aortic stenosis, case-mix adjustment, outcomes analysis, outcomes research, transcatheter aortic valve replacement",
author = "O'Brien, {Sean M.} and Cohen, {David J.} and Rumsfeld, {John S.} and Brennan, {J. Matthew} and Shahian, {David M.} and David Dai and David Holmes and Hakim, {Rosemarie B.} and Thourani, {Vinod H.} and Peterson, {Eric D.} and Edwards, {Fred H.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1161/CIRCOUTCOMES.116.002756",
language = "English (US)",
volume = "9",
pages = "560--565",
journal = "Circulation: Cardiovascular Quality and Outcomes",
issn = "1941-7713",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Variation in hospital risk-adjusted mortality rates following transcatheter aortic valve replacement in the United States

AU - O'Brien, Sean M.

AU - Cohen, David J.

AU - Rumsfeld, John S.

AU - Brennan, J. Matthew

AU - Shahian, David M.

AU - Dai, David

AU - Holmes, David

AU - Hakim, Rosemarie B.

AU - Thourani, Vinod H.

AU - Peterson, Eric D.

AU - Edwards, Fred H.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Background - The use of transcatheter aortic valve replacement (TAVR) to treat aortic stenosis in the United States is growing, yet little is known about the variation in procedural outcomes in community practice. We developed a TAVR in-hospital mortality risk model and used it to quantify variation in mortality rates across United States (US) TAVR centers. Methods and Results - We analyzed data from 22 248 TAVR procedures performed at 318 sites participating in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (November 2011 to October 2014). A Bayesian hierarchical model was developed to estimate hospital-specific risk-adjusted mortality rates adjusting for 40 patient baseline factors. A total of 1130 in-hospital deaths (5.1%) were observed. Reliability-adjusted risk-adjusted mortality rate estimates ranged from 3.4% to 7.7% with an interquartile range of 4.8% to 5.4%. A patient's predicted odds of dying was 80% higher if treated by a hospital 1 standard deviation above the mean compared with a hospital 1 standard deviation below the mean (odds ratio =1.8; 95% credible interval, 1.4%-2.2%). Conclusions - Risk modeling of TAVR in-hospital mortality revealed variation in risk-adjusted mortality rates during the US early commercial experience. Transcatheter Valve Therapy Registry analyses using this model will support research, feedback reporting, and the identification of factors associated with quality.

AB - Background - The use of transcatheter aortic valve replacement (TAVR) to treat aortic stenosis in the United States is growing, yet little is known about the variation in procedural outcomes in community practice. We developed a TAVR in-hospital mortality risk model and used it to quantify variation in mortality rates across United States (US) TAVR centers. Methods and Results - We analyzed data from 22 248 TAVR procedures performed at 318 sites participating in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (November 2011 to October 2014). A Bayesian hierarchical model was developed to estimate hospital-specific risk-adjusted mortality rates adjusting for 40 patient baseline factors. A total of 1130 in-hospital deaths (5.1%) were observed. Reliability-adjusted risk-adjusted mortality rate estimates ranged from 3.4% to 7.7% with an interquartile range of 4.8% to 5.4%. A patient's predicted odds of dying was 80% higher if treated by a hospital 1 standard deviation above the mean compared with a hospital 1 standard deviation below the mean (odds ratio =1.8; 95% credible interval, 1.4%-2.2%). Conclusions - Risk modeling of TAVR in-hospital mortality revealed variation in risk-adjusted mortality rates during the US early commercial experience. Transcatheter Valve Therapy Registry analyses using this model will support research, feedback reporting, and the identification of factors associated with quality.

KW - aortic stenosis

KW - case-mix adjustment

KW - outcomes analysis

KW - outcomes research

KW - transcatheter aortic valve replacement

UR - http://www.scopus.com/inward/record.url?scp=84988458283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988458283&partnerID=8YFLogxK

U2 - 10.1161/CIRCOUTCOMES.116.002756

DO - 10.1161/CIRCOUTCOMES.116.002756

M3 - Article

C2 - 27625404

AN - SCOPUS:84988458283

VL - 9

SP - 560

EP - 565

JO - Circulation: Cardiovascular Quality and Outcomes

JF - Circulation: Cardiovascular Quality and Outcomes

SN - 1941-7713

IS - 5

ER -